concept_id,ingredient_concept_name,drug_name,atc,atc_1,atc_2,atc_3,atc_4,exclude_reason
1736971,abacavir,abacavir,J05AF06 ,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
1594148,abaloparatide,abaloparatide,H05AA04,"systemic hormonal preparations, excl. sex hormones and insulins",calcium homeostatsis,parathyroid hormones and analogues,parathyroid hormones and analogues,
1186087,abatacept,abatacept,L04AA24,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
792649,abemaciclib,abemaciclib,L01EF03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Cyclin-dependent kinase (CDK) inhibitors,
40239056,abiraterone,abiraterone,L02BX03,antineoplastic and immunomodulating agents,endocrine therapy,hormone antagonists and related agents,other hormone antagonists and related agents,
1758974,abrocitinib,abrocitinib,D11AH08,dermatologicals ,other dermatological preparations,other dermatological preparations,"agents for dermatitis, excluding corticosteroids",
792764,acalabrutinib,acalabrutinib,L01EL02 ,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Bruton's tyrosine kinase (BTK) inhibitors,
36861566,ACORAMIDIS,acoramidis,C01EB25,cardiovascular system,cardiac therapy,other cardiac preparations,other cardiac preparations,
1119119,adalimumab,adalimumab,L04AB04,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,tumor necrosis factor alpha (TNF-α) inhibitors,
1537087,aducanumab,aducanumab,N06DX03,nervous system,psychoanaleptics,anti-dementia drugs,other anti-dementia drugs,
37497655,afamelanotide,afamelanotide,D02BB02,dermatologicals ,emollients and protectives,protectives against UV-radiation,protectives against UV-radiation for systemic use,
36856432,AFAMITRESGENE AUTOLEUCEL,afamitresgene autoleucel,NA,unassigned,unassigned,unassigned,unassigned,
43533090,afatinib,afatinib,L01EB03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
40244266,aflibercept,aflibercept,L01XX44; S01LA05,antineoplastic and immunomodulating agents; sensory organs,antineoplastic agents; ophthalmologicals,other antineoplastic agents; ocular vascular disorder agents,other antineoplastic agents; antineovascularisation agents,
36878851,Agalsidase alfa,agalsidase alfa,A16AB03,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1525746,agalsidase beta,agalsidase beta,A16AB04,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1309770,aldesleukin,aldesleukin,L03AC01,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,interleukins,
35604657,alectinib,alectinib,L01ED03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,anaplastic lymphoma kinase (ALK) inhibitors,
1312706,alemtuzumab,alemtuzumab,L04AG06,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
19088328,alglucosidase alfa,alglucosidase alfa,A16AB07,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1396423,alpelisib,alpelisib,L01EM03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,
1337068,ambrisentan,ambrisentan,C02KX02,cardiovascular system,antihypertensives,other antihypertensives,antihypertensives for pulmonary arterial hypertension,
1355889,amifampridine,"3,4-diaminopyridine",N07XX05,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
1790868,amikacin,amikacin inhalation,S01AA21,antiinfectives for systemic use,antibacterials for systemic use,aminoglycoside antibacterials,other aminoglycosides,
1536935,amivantamab,amivantamab,L01FX18,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
1114375,anakinra,anakinra,L04AC03,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
19026450,anidulafungin,anidulafungin,J02AX06,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,other antimycotics for systemic use,
701470,anifrolumab,anifrolumab,L04AG11,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
19136041,antilymphocyte immunoglobulin,antilymphocyte globulin,,,,,,
1436169,antithrombin III,antithrombin iii,B01AB02,blood and blood forming organs,antithrombotic agents,antithrombotic agents,heparin group,
36861990,Apadamtase Alfa,apadamtase alfa,,,,,,
963987,apalutamide,apalutamide,L02BB05,antineoplastic and immunomodulating agents,endocrine therapy,hormone antagonists and related agents,anti-androgens,
36857097,ARIMOCLOMOL,arimoclomol,N07XX17,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
1333379,arsenic trioxide,arsenic trioxide,L01XX27,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
702133,asciminib,asciminib,L01EA06 ,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,BCR-ABL tyrosine kinase inhibitors,
35603109,asfotase alfa,asfotase alfa,A16AB13,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
36858752,ATACICEPT,atacicept,,,,,,
36879015,Ataluren,ataluren,M09AX03,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
1727223,atazanavir,atazanavir,J05AE08,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
42629079,atezolizumab,atezolizumab,L01FF05,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
42609446,atidarsagene autotemcel,atidarsagene autotemcel,A16AB21,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
36118943,Autologous anti-CD19-transduced CD3+ cells,autologous anti-cd19-transduced cd3+ cells - kte-x19,,,,,,
40224705,autologous cultured chondrocytes,autologous human chondrocyte implantation,,,,,,
40684592,Autologous human corneal epithelial cells,ex-vivo expanded autologous human corneal epithelial cells containing stem cells,,,,,,
702027,avacopan,avacopan,L04AJ05 ,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
701512,avalglucosidase alfa,avalglucosidase alfa,A16AB22,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
36849834,AVALOTCAGENE ONTAPARVOVEC,avalotcagene ontaprvovec,,,,,,
37498468,avapritinib,avapritinib,L01EX18,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1593273,avelumab,avelumab,L01FF04,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
792844,axicabtagene ciloleucel,axicabtagene ciloleucel,L01XL03,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
42709322,axitinib,axitinib,L01EK01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,
1314865,azacitidine,azacitidine,L01BC07,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,pyrimidine analogues,
19014878,azathioprine,azathioprine,L04AX01,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
36856334,BARDOXOLONE METHYL,bardoxolone methyl,,,,,,
1510627,baricitinib,baricitinib,L04AF02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,Janus-associated kinase (JAK) inhibitors,
19038440,basiliximab,basiliximab,L04AC02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
36859649,BECLABUVIR,beclabuvir,,,,,,
43012518,bedaquiline,bedaquiline,J04AK05,antiinfectives for systemic use,antimycobacterials,drugs for treatment of tuberculosis,other drugs for treatment of tuberculosis,
36850748,BEGELOMAB,begelomab,L04AG07,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
37002419,belantamab mafodotin,belantamab mafodotin,L01FX15,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
40239665,belatacept,belatacept,L04AA28,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
40236987,belimumab,belimumab,L04AG04,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
701423,belumosudil,belumosudil,L04AA48 ,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
701696,belzutifan,belzutifan,L01XX74 ,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
19015523,bendamustine,bendamustine,L01AA09,antineoplastic and immunomodulating agents,antineoplastic agents,alkylating agents,nitrogen mustard analogues,
792993,benralizumab,benralizumab,R03DX10,respiratory system,drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,
37003361,berotralstat,berotralstat,B06AC06,blood and blood forming organs,other hematological agents,other hematological agents,drugs used in hereditary angioedema,
1520218,betaine,betaine,A16AA06,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,amino acids and derivatives,
1397141,bevacizumab,bevacizumab,L01FG01; S01LA08,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,
964008,bictegravir,bictegravir,,,,,,
36859672,BIMAGRUMAB,bimagrumab,,,,,,
1559930,binimetinib,binimetinib,L01EE03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,mitogen-activated protein kinase (MEK) inhibitors,
19024770,biotin,biotin,A11HA05,alimentary tract and metabolism,vitamins  ,other plain vitamin preparations,other plain vitamin preparations,
36856600,BIZALIMOGENE RALAPLASMID,bizalimogene ralaplasmid,,,,,,
45892531,blinatumomab,blinatumomab,L01FX07,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
1336825,bortezomib,bortezomib,L01XG01,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,proteasome inhibitors,
1321636,bosentan,bosentan,C02KX01,cardiovascular system,antihypertensives,other antihypertensives,antihypertensives for pulmonary arterial hypertension,
42900401,bosutinib,bosutinib,L01EA04,antineoplastic and immunomodulating agents,antithrombotic agents,protein kinase inhibitors ,BCR-ABL tyrosine kinase inhibitors,
36858299,BOTARETIGENE SPAROPARVOVEC,botaretigene sparoparvovec,,,,,,
36856245,BRENTUXIMAB,brentuximab,,,,,,
37002369,brexucabtagene autoleucel,brexucabtagene autoleucel,L01XL06,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
1594187,brigatinib,brigatinib,L01ED04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,anaplastic lymphoma kinase (ALK) inhibitors,
36850307,BRIMAPITIDE,brimapitide,,,,,,
19030387,bromelains,nexobrid (bromelain),D03BA03; M09AB03 ,dermatologicals; musculo-skeletal system,preparations for treatment of wounds and ulcers; other drugs for disorders of the musculo-skeletal system,enzymes; other drugs for disorders of the musculo-skeletal system,proteolytic enzymes; enzymes,
36042920,Bulevirtide,bulevirtide,J05AX28,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
1510235,burosumab,burosumab,M05BX05,musculo-skeletal system,drugs for treatment of bone diseases,drugs affecting bone structure and mineralization,other drugs affecting bone structure and mineralization,
45892906,C1 esterase inhibitor,c1 esterase inhibitors,,,,,,
40222431,cabazitaxel,cabazitaxel,L01CD04,antineoplastic and immunomodulating agents,antineoplastic agents,plant alkaloids and other natural products,taxanes,
739588,cabotegravir,cabotegravir,J05AJ04,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,integrase inhibitors,
43012292,cabozantinib,cabozantinib,L01EX07,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
19035569,calcifediol,calcifediol,A11CC06; H05BX05,"alimentary tract and metabolism; systemic hormonal preparations, excl. sex hormones and insulins",vitamins; calcium homeostasis,"vitamin A and D, incl. combinations of the two; anti-parathyroid agents",vitamin D and analogues; other anti-parathyroid agents,
40161669,canakinumab,canakinumab,L04AC08,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
1510417,cannabidiol,cannabidiol,N03AX24,nervous system,antiepileptics,antiepileptics,other antiepileptics,
1366428,caplacizumab,caplacizumab,B01AX07,blood and blood forming organs,antithrombotic agents,antithrombotic agents,other antithrombotic agents,
1145637,capmatinib,capmatinib,L01EX17,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
42873638,carfilzomib,carfilzomib,L01XG02,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,proteasome inhibitors,
19102150,carglumic acid,carglumic acid,A16AA05,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,amino acids and derivatives,
19050104,carnitine,carnitine,,,,,,
1718054,caspofungin,caspofungin,J02AX04,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,other antimycotics for systemic use,
35200783,cemiplimab,cemiplimab,L01FF06,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
1355548,cenegermin,cenegermin,S01XA24,sensory organs,ophthalmologicals,other ophthalmologicals,other ophthalmologicals,
44818466,ceritinib,ceritinib,L01ED02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,anaplastic lymphoma kinase (ALK) inhibitors,
1315411,cetuximab,cetuximab,L01FE01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,EGFR (Epidermal Growth Factor Receptor) inhibitors,
44506782,cholic acid,cholic acid,A05AA03,alimentary tract and metabolism,bile and liver therapy,bile therapy,bile acids and derivatives,
779144,ciltacabtagene autoleucel,ciltacabtagene autoleucel,L01XL05,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
746789,cipaglucosidase alfa,cipaglucosidase alfa,A16AB23,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1797513,ciprofloxacin,ciprofloxacin  inhalation,J01MA02,antiinfectives for systemic use,antibacterials for systemic use,quinolone antibacterials,fluoroquinolones,
19054825,cladribine,cladribine,L01BB04; L04AA40 ,antineoplastic and immunomodulating agents,antineoplastic agents; immunosuppressants,antimetabolites; immunosuppressants,purine analogues; selective immunosuppressants,
19054821,clofarabine,clofarabine,L01BB06,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,purine analogues,
44818493,coagulation factor IX recombinant immunoglobulin G1 fusion protein,eftrenonacog alfa (efrenonacog alfa) (factor ix - recombinant),,,,,,
42874220,cobicistat,cobicistat,V03AX03,various,all other therapeutic products,all other therapeutic products,other therapeutic products,
35605804,cobimetinib,cobimetinib,L01EE02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,mitogen-activated protein kinase (MEK) inhibitors,
36878774,Colestilan,colestilan,V03AE06,various,all other therapeutic products,all other therapeutic products,drugs for treatment of hyperkalemia and hyperphosphatemia,
36852954,CONCIZUMAB,concizumab,B02BX10,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,other systemic hemostatics,
36878937,Conestat alfa,conestat alfa,B06AC04,blood and blood forming organs,other hematological agents,other hematological agents,drugs used in hereditary angioedema,
40242675,crizotinib,crizotinib,L01ED01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,anaplastic lymphoma kinase (ALK) inhibitors,
36857968,CROVALIMAB,crovalimab,L04AJ07,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
19010482,cyclosporine,ciclosporin,L04AD01; S01XA18,antineoplastic and immunomodulating agents; sensory organs,immunosuppressants; ophthalmologicals,immunosuppressants; other ophthalmologicals,calcineurin inhibitors; other ophthalmologicals,
910888,cysteamine,cysteamine (mercaptamine),A16AA04; S01XA21,alimentary tract and metabolism; sensory organs,other alimentary tract and metabolism products; ophthalmologicals,other alimentary tract and metabolism products; other ophthalmologicals,amino acids and derivatives; other ophthalmologicals,
902730; 1311799,"Cytarabine liposomal; 	daunorubicin",liposomal cytarabine-daunorubicin,L01XY01,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,combinations of antineoplastic agents,multiple ingredients
43532299,dabrafenib,dabrafenib,L01EC02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,B-Raf serine-threonine kinase (BRAF) inhibitors,
35200803,dacomitinib,dacomitinib,L01EB07,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
35200416,damoctocog alfa pegol,damoctocog alfa pegol (factor viii - recombinant),,,,,,
42609527,danicopan; DANICOPAN,danicopan,L04AJ09,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
35605744,daratumumab,daratumumab,L01FC01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD38 (Clusters of Differentiation 38) inhibitors,
1304643,darbepoetin alfa,darbepoetin alpha,,,,,,
1361291,darolutamide,darolutamide,L02BB06,antineoplastic and immunomodulating agents,endocrine therapy,hormone antagonists and related agents,anti-androgens,
1756831,darunavir,darunavir,J05AE10,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
45892558,dasabuvir,dasabuvir,J05AP09,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,
1358436,dasatinib,dasatinib,L01EA02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,BCR-ABL tyrosine kinase inhibitors,
19024728,decitabine,decitabine,L01BC08,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,pyrimidine analogues,
1786055,deferasirox,deferasirox,V03AC03,various,all other therapeutic products,all other therapeutic products,iron chelating agents,
19011091,deferiprone,deferiprone,V03AC02,various,all other therapeutic products,all other therapeutic products,iron chelating agents ,
42898933,defibrotide,defibrotide,B01AX01,blood and blood forming organs,antithrombotic agents,antithrombotic agents,other antithrombotic agents,
36879076,Delamanid,delamanid,J04AK06,antiinfectives for systemic use; sensory organs,antimycobacterials,drugs for treatment of tuberculosis,other drugs for treatment of tuberculosis,
746024,delandistrogene moxeparvovec,delandistrogene moxaparvovec,,,,,,
1518254,dexamethasone,dexamethasone  intra-erythrocyte,,,,,,
1353011,dexrazoxane,dexrazoxane,V03AF02,various,all other therapeutic products,all other therapeutic products,detoxifying agents for antineoplastic treatment,
36879004,Dibotermin alfa,dibotermin alfa,M05BC01,musculo-skeletal system,drugs for treatment of bone diseases,drugs affecting bone structure and mineralization,bone morphogenetic proteins,
1724869,didanosine,didanosine,J05AF02,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
701764,difelikefalin,difelikefalin,V03AX04,various,all other therapeutic products,all other therapeutic products,other therapeutic products,
43526424,dimethyl fumarate,dimethyl fumarate,L04AX07,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
40685018,Dinutuximab beta,dinutuximab beta,L01FX06,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
36858087,DIRLOCTOCOGENE SAMOPARVOVEC,dirlococtogene samoparvovec,,,,,,
37497593,diroximel fumarate,diroximel fumarate,L04AX09,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
1315942,docetaxel,docetaxel,L01CD02,antineoplastic and immunomodulating agents,antineoplastic agents,plant alkaloids and other natural products,taxanes,
43560385,dolutegravir,dolutegravir,J05AJ03,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,integrase inhibitors,
35200446,doravirine,doravirine,J05AG06,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,non-nucleoside reverse transcriptase inhibitors,
1125443,dornase alfa,dornase alfa,R05CB13,respiratory system,cough and cold preparations,"expectorants, excl. combinations with cough suppressants",mucolytics,
1536789,dostarlimab,dostarlimab,L01FF07,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
902725,Doxorubicin pegylated liposomal,pegylated liposomal doxorubicin,,,,,,
1593467,dupilumab,dupilumab,D11AH05,dermatologicals ,other dermatological preparations,other dermatological preparations,"agents for dermatitis, excluding corticosteroids",
1594034,durvalumab,durvalumab,L01FF03,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
35200763,duvelisib,duvelisib,L01EM04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,
40168938,ecallantide,ecallantide,B06AC03,blood and blood forming organs,other hematological agents,other hematological agents,drugs used in hereditary angioedema,
19080458,eculizumab,eculizumab,L04AJ01 ,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
1253104,Efanesoctocog Alfa,efanesoctocog alfa,,,,,,
1738135,efavirenz,efavirenz,J05AG03 ,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,non-nucleoside reverse transcriptase inhibitors,
702468,efgartigimod alfa,efgartigimod alfa,L04AA58,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
45776421,efmoroctocog alfa,efmoroctocog alfa (efraloctocog alfa) (factor viii - recombinant),,,,,,
36861297,ELADOCAGENE EXUPARVOVEC,eladocagene exuparvovec,A16AB26,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
36850289,ELAFIBRANOR,elafibranor,A05AX06,alimentary tract and metabolism,bile and liver therapy,bile therapy,other drugs for bile therapy ,
35606465,elbasvir,elbasvir,J05AP10,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,
37497446; 963950; 42709323,elexacaftor; tezacaftor; ivacaftor,elexacaftor + tezacaftor + ivacaftor,R07AX32,respiratory system,other respiratory system products,other respiratory system products,other respiratory system products,multiple ingredients
45775782,eliglustat,eliglustat,A16AX10,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
44814525,elosulfase alfa,elosulfase alfa,A16AB12,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
35604032,elotuzumab,elotuzumab,L01FX08,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
746391,elranatamab,elranatamab,L01FX32,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
42874212,elvitegravir,elvitegravir,J05AJ02,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,integrase inhibitors,
36859341,ELVUCITABINE,elvucitabine,,,,,,
793042,emicizumab,emicizumab,B02BX06,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,other systemic hemostatics,
36856715,EMIPLACEL,emiplacel,,,,,,
36848654,EMIXUSTAT,emixustat,,,,,,
1703069,emtricitabine,emtricitabine,J05AF09,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
1559914,encorafenib,encorafenib,L01EC03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,B-Raf serine-threonine kinase (BRAF) inhibitors,
1717002,enfuvirtide,enfuvirtide,J05AX07,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
37496447,entrectinib,entrectinib,L01EX14,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
42900250,enzalutamide,enzalutamide,L02BB04,antineoplastic and immunomodulating agents,endocrine therapy,hormone antagonists and related agents,anti-androgens,
1201211,epcoritamab,epcoritamab,L01FX27,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
42608839,eplontersen,eplontersen,N07XX21,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
1301125,epoetin alfa,epoetin alfa,,,,,,
19001311,epoetin beta,epoetin beta,,,,,,
36878928,epoetin theta,epoetin theta,,,,,,
36878697,epoetin zeta,epoetin zeta,,,,,,
1354118,epoprostenol,epoprostenol,B01AC09,blood and blood forming organs,antithrombotic agents,antithrombotic agents,platelet aggregation inhibitors excl. heparin,
36850565,EPRATUZUMAB,epratuzumab,,,,,,
36853254,EPRODISATE,eprodisate,,,,,,
36922870,Eptacog beta activated,eptacog beta (activated) (factor viia - recombinant),,,,,,
40230712,eribulin,eribulin,L01XX41,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
1325363,erlotinib,erlotinib,L01EB02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
1151789,etanercept,etanercept,L04AB01,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,tumor necrosis factor alpha (TNF-α) inhibitors,
40220748,eteplirsen,eteplirsen,M09AX06,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
1301479,etranacogene dezaparvovec,etranacogene dezaparvovec,B02BD16,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
746899,etrasimod,etrasimod,L04AE05,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,Sphingosine-1-phosphate (S1P) receptor modulators,
1758536,etravirine,etravirine,J05AG04,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,non-nucleoside reverse transcriptase inhibitors,
19011440,everolimus,everolimus,L01EG02; L04AH02,antineoplastic and immunomodulating agents,antineoplastic agents; immunosuppressants,protein kinase inhibitors; immunosuppressants,mammalian target of rapamycin (mTOR) kinase inhibitors,
739794,evinacumab,evinacumab,C10AX17,cardiovascular system,lipid modifying agents,"lipid modifying agents, plain",other lipid modifying agents,
46287466,evolocumab,evolocumab,C10AX13,cardiovascular system,lipid modifying agents,"lipid modifying agents, plain",other lipid modifying agents,
747499,exagamglogene autotemcel,exagamglogene autotemcel,B06AX05,blood and blood forming organs,other hematological agents,other hematological agents,other hematological agents,
1351935,factor IX,factor ix - see drug names,B02BD04,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
44785020,factor VII,factor vii,B02BD05,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
1352141,factor VIIa,factor viia - see drug names,B02BD08,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
1352213,factor VIII,factor viii - see drug names,B02BD02,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
44785022,factor X,factor x (see human coagulation factor x) (factor x - plasma derived),B02BD13,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
36879148,Factor XI,factor xi,,,,,,
19106100,factor XIII,factor xiii (factor xiii - plasma derived),B02BD07,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
36878867,Fampiridine,fampridine,N07XX07,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
1361614,fedratinib,fedratinib,L01EJ02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Janus-associated kinase (JAK) inhibitors,
753860,fenfluramine,fenfluramine,A08AA02; N03AX26,alimentary tract and metabolism; nervous system,"antiobesity preparations, excl. diet products; antiepileptics","antiobesity preparations, excl. diet products; antiepileptics",centrally acting antiobesity products; other antiepileptics,
19054702,fibrinogen,fibrinogen,,,,,,
1734324,fidanacogene elaparvovec,fidanacogene elaparvovec,B02BD17,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
40226579,fingolimod,fingolimod,L04AE01,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,sphingosine-1-phosphate (S1P) receptor modulators,
36861527,FITUSIRAN,fitusiran,,,,,,
36857896,FORDADISTROGENE MOVAPARVOVEC,fordadistrogene movaparvovec,,,,,,
1736829,fosamprenavir,fosamprenavir,J05AE07,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
36845627,FOSDENOPTERIN,fosdenopterin (cyclic pyranopterin monophosphate),A16AX19,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
1146410,fostemsavir,fostemsavir,J05AX29,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
1301597,futibatinib,futibatinib,L01EN04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,
19078649,galsulfase,galsulfase,A16AB08,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
780003,ganaxolone,ganaxolone,N03AX27,nervous system,antiepileptics,antiepileptics,other antiepileptics,
1319193,gefitinib,gefitinib,L01EB01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
1314924,gemcitabine,gemcitabine,L01BC05,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,pyrimidine analogues,
1314924; 1337620,gemcitabine; capecitabine,gemcitabine (with capecitabine),,,,,,multiple ingredients
42799711,gemtuzumab ozogamicin,gemtuzumab ozogamicin,L01FX02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
1355513,gilteritinib,gilteritinib,L01EX13,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
36856211,GIROCTOCOGENE FITELPARVOVEC,giroctocogene fitelparvovec,,,,,,
37498020,givosiran,givosiran,A16AX16,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
751889,glatiramer,glatiramer,,,,,,
793843,glecaprevir,glecaprevir,,,,,,
1201501,glofitamab,glofitamab,L01FX28,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
42709319,glucarpidase,glucarpidase,V03AF09,various,all other therapeutic products,all other therapeutic products,detoxifying agents for antineoplastic treatment,
46274595,glycerol phenylbutyrate,glycerol phenylbutyrate,A16AX09,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
35606467,grazoprevir,grazoprevir,J05AP11,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,
19068899,heme arginate,haem arginate,,,,,,
40798876,Human Alpha1 Proteinase Inhibitor,human alpha1-proteinase inhibitor,,,,,,
36852550,HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX,factor viii + von willebrand factor (von willebrand factor - plasma with fviii),B02BD06,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
42544019,ibalizumab,ibalizumab,J05AX23,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
44507848,ibrutinib,ibrutinib,L01EL01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,Bruton's tyrosine kinase (BTK) inhibitors,
40242044,icatibant,icatibant,B06AC02,blood and blood forming organs,other hematological agents,other hematological agents,drugs used in hereditary angioedema,
19067036,idebenone,idebenone,N06BX13,nervous system,psychoanaleptics,"psychostimulants, agents used for ADHD and nootropics",other psychostimulants and nootropics,
36026868,idecabtagene vicleucel,idecabtagene vicleucel,L01XL07,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
45776944,idelalisib,idelalisib,L01EM01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Phosphatidylinositol-3-kinase (Pi3K) inhibitors,
19091430,idursulfase,idursulfase,A16AB09,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1344992,iloprost,iloprost,B01AC11,blood and blood forming organs,antithrombotic agents,antithrombotic agents,platelet aggregation inhibitors excl. heparin,
1304107,imatinib,imatinib,L01EA01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,BCR-ABL tyrosine kinase inhibitors,
1734581,imetelstat,imetelstat,L01XX80,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
1348407,imiglucerase,imiglucerase,A16AB02,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
35894914,Imlifidase,imlifidase,L04AA41,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
1758562,inclisiran,inclisiran,C10AX16,cardiovascular system,lipid modifying agents,"lipid modifying agents, plain",other lipid modifying agents,
1711523,indinavir,indinavir,J05AE02,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
1146077,inebilizumab,inebilizumab,L04AG10,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
937368,infliximab,infliximab,L04AB02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,tumor necrosis factor alpha (TNF-α) inhibitors,
35200990,inotersen,inotersen,N07XX15,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
794068,inotuzumab ozogamicin,inotuzumab ozogamicin,L01FB01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD22 (Clusters of Differentiation 22) inhibitors,
1385645,interferon alfa-n3,interferon alfa n3,,,,,,
19109079,interferon-beta,interferon beta,,,,,,
44012679,Invertase,invertase,,,,,,
40238188,ipilimumab,ipilimumab,L01FX04,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
747398,iptacopan,iptacopan,L04AJ08,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
37498969,isatuximab,isatuximab,L01FC02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD38 (Clusters of Differentiation 38) inhibitors,
35606695,isavuconazole,isavuconazole,J02AC05,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,triazole and tetrazole derivatives,
42709323,ivacaftor,ivacaftor,R07AX02,respiratory system,other respiratory system products,other respiratory system products,other respiratory system products,
1560123,ivosidenib,ivosidenib,L01XM02,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,isocitrate dehydrogenase (IDH) inhibitors,
35606214,ixazomib,ixazomib,L01XG03,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,proteasome inhibitors,
35200405,lanadelumab,lanadelumab,B06AC05,blood and blood forming organs,other hematological agents,other hematological agents,drugs used in hereditary angioedema,
1503501,lanreotide,lanreotide,H01CB03,"systemic hormonal preparations, excl. sex hormones and insulins",pituitary and hypothalamic hormones and analogues,hypothalamic hormones,somatostatin and analogues,
1359548,lapatinib,lapatinib,L01EH01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,
35197979,l-arginine,l-arginine,,,,,,
1543229,laronidase,laronidase,A16AB05,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1355705,larotrectinib,larotrectinib,L01EX12,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1735356,lebrikizumab,lebrikizumab,D11AH10,dermatologicals,other dermatological preparations,other dermatological preparations,"agents for dermatitis, excluding corticosteroids",
36860138,LENABASUM,lenabasum (anabasum),,,,,,
1301335,lenacapavir,lenacapavir,J05AX31,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
36862990,LENADOGENE NOLPARVOVEC,lenadogene nolparvovec,,,,,,
19026972,lenalidomide,lenalidomide,L04AX04,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
1302040,leniolisib,leniolisib,L03AX22,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,other immunostimulants,
46221433,lenvatinib,lenvatinib,L01EX08,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
36858814,LERIGLITAZONE,leriglitazone,A16AX23,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
32994,leronlimab,leronlimab,,,,,,
792929,letermovir,letermovir,J05AX18,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
36855862,LETETRESGENE AUTOLEUCEL,letetresgene autoleucel,,,,,,
789578; 740561,levodopa; carbidopa,levodopa + carbidopa intestinal gel,,,,,,multiple ingredients
789578; 740560; 782211,levodopa; carbidopa; entacapone,levodopa + carbidopa + entacapone (intestinal gel),,,,,,multiple ingredients
1742253,levofloxacin,levofloxacin (inhaled),J01MA12 ,antiinfectives for systemic use,antibacterials for systemic use,quinolone antibacterials,fluoroquinolones,
36850192,LEVOKETOCONAZOLE,levoketoconazole,H02CA04,"systemic hormonal preparations, excl. sex hormones and insulins",corticosteroids for systemic use,antiadrenal preparations,anticorticosteroids,
42609269,lifileucel,lifileucel,L01XL11,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
739856,lisocabtagene maraleucel,lisocabtagene maraleucel,L01XL08,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
43013119,lomitapide,lomitapide,C10AX12,cardiovascular system,lipid modifying agents,"lipid modifying agents, plain",other lipid modifying agents,
37003374,lonafarnib,lonafarnib,A16AX20,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
36859960,LONCASTUXIMAB,loncastuximab,,,,,,
1738170,lopinavir,lopinavir,,,,,,
35201733,lorlatinib,lorlatinib,L01ED05,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,anaplastic lymphoma kinase (ALK) inhibitors,
46275580; 42709324,lumacaftor; ivacaftor,lumacaftor + ivacaftor,R07AX30,respiratory system,other respiratory system products,other respiratory system products,other respiratory system products,multiple ingredients
37003331,lumasiran,lumasiran,A16AX18,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
37497705,luspatercept,luspatercept,B03XA06,blood and blood forming organs,antianemic preparations,other antianemic preparations,other antianemic preparations,
36857581,LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN,lutetium (177lu) vipivotide tetraxetan,V10XX05,various,therapeutic radiopharmaceuticals ,other therapeutic radiopharmaceuticals,various therapeutic radiopharmaceuticals,
44507580,macitentan,macitentan,C02KX04,cardiovascular system,antihypertensives,other antihypertensives,antihypertensives for pulmonary arterial hypertension,
994058,mannitol,mannitol (inhaled),R05CB16,respiratory system,cough and cold preparations,"expectorants, excl. combinations with cough suppressants",mucolytics,
701940,maralixibat,maralixibat,,,,,,
1787101,maraviroc,maraviroc,J05AX09,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
702291,maribavir,maribavir,J05AX10,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,other antivirals,
1253798,Marnetegragene Autotemcel,marnetegragene autotemcel,,,,,,
1735606,marstacimab,marstacimab,B02BX11,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,other systemic hemostatics,
36859404,MASITINIB,masitinib,L01EX06,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,other protein kinase inhibitors,
779591,mavacamten,mavacamten,C01EB24,cardiovascular system,cardiac therapy,other cardiac preparations,other cardiac preparations,
1502877,mecasermin,mecasermin,H01AC03,"systemic hormonal preparations, excl. sex hormones and insulins",pituitary and hypothalamic hormones and analogues,anterior pituitary lobe hormones and analogues,somatropin and somatropin agonists,
35606631,mepolizumab,mepolizumab,R03DX09,respiratory system,drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,
44814585,metreleptin ,metreleptin ,,,,,,
1307542,mexiletine,mexiletine,C01BB02,cardiovascular system,cardiac therapy,"antiarrhythmics, class i and iii","antiarrhythmics, class Ib",
19018013,micafungin,micafungin,J02AX05,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,other antimycotics for systemic use,
1594003,midostaurin,midostaurin,L01EX10,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
36878942,Mifamurtide,mifamurtide,L03AX15,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,other immunostimulants,
35200267,migalastat,migalastat,A16AX14,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
19045272,miglustat,miglustat,A16AX06,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
779081,mitapivat,mitapivat,B06AX04,blood and blood forming organs,other hematological agents,other hematological agents,other hematological agents,
701915,mobocertinib,mobocertinib,L01EB10,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
35200202,mogamulizumab,mogamulizumab,L01FX09,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
746600,momelotinib,momelotinib,L01EJ04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,Janus-associated kinase (JAK) inhibitors,
1301307,mosunetuzumab,mosunetuzumab,L01FX25,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
36856592,MOZAFANCOGENE AUTOTEMCEL,mozafancogene autotemcel,,,,,,
19003999,mycophenolate mofetil,mycophenolate mofetil,,,,,,
19012565,mycophenolic acid,mycophenolic acid (sodium salt),L04AA06,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,selective immunosuppressants,
NA,NA,"albutrepenonacog alfa
(factor ix - recombinant)",NA,,,,,no ingredient concept found
NA,NA,amifampridine phosphate,NA,,,,,no ingredient concept found
NA,NA,amikacin liposomal (inhaled),NA,,,,,no ingredient concept found
NA,NA,amphotericin liposomal,,,,,,no ingredient concept found
NA,NA,antithymocyte immunoglobulin,,,,,,no ingredient concept found
NA,NA,autologous & allogenic serum eye drops,,,,,,no ingredient concept found
NA,NA,autologous lentiviral was stem cell therapy,,,,,,no ingredient concept found
NA,NA,aztreonam lysine,,,,,,no ingredient concept found
NA,NA,birch bark extract,,,,,,no ingredient concept found
NA,NA,bis-choline tetrathiomolybdate,,,,,,no ingredient concept found
NA,NA,brain cancer vaccine,,,,,,no ingredient concept found
NA,NA,"calcium, magnesium, potassium + sodium oxybate",,,,,,no ingredient concept found
NA,NA,canpuldencel-t,,,,,,no ingredient concept found
NA,NA,"catridecacog
(factor xiii - recombinant)",B02BD11,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,no ingredient concept found
NA,NA,cerliponase alfa,A16AB17,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,no ingredient concept found
NA,NA,chemotherapy,,,,,,no ingredient concept found
NA,NA,chenodeoxycholic acid,A05AA01,alimentary tract and metabolism,bile and liver therapy,bile therapy,bile acids and derivatives,no ingredient concept found
NA,NA,chlormethine,L01AA05,antineoplastic and immunomodulating agents,antineoplastic agents,alkylating agents,nitrogen mustard analogues,no ingredient concept found
NA,NA,ciprofloxacin liposomal (inhaled),,,,,,no ingredient concept found
NA,NA,colistimethate sodium,,,,,,no ingredient concept found
NA,NA,copper histidinate,,,,,,no ingredient concept found
NA,NA,desferrioxamine,,,,,,no ingredient concept found
NA,NA,"efraloctocog alfa (see efmoroctocog alfa)
(factor viii - recombinant)",,,,,,no ingredient concept found
NA,NA,"efrenonacog alfa (see eftrenonacog alfa)
(factor ix - recombinant)",,,,,,no ingredient concept found
NA,NA,enfortumab vedotin,L01FX13,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,no ingredient concept found
NA,NA,"eptacog alfa (activated)
(factor viia - recombinant)",,,,,,no ingredient concept found
NA,NA,factor viii inhibitor bypassing fraction,B02BD03,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,no ingredient concept found
NA,NA,forigerimod acetate,,,,,,no ingredient concept found
NA,NA,foslevodopa-foscarbidopa,,,,,,no ingredient concept found
NA,NA,"high purity factor ix
(factor ix - plasma derived)",,,,,,no ingredient concept found
NA,NA,"high purity factor viii 
(factor viii - plasma derived)",,,,,,no ingredient concept found
NA,NA,human coagulation factor x,,,,,,no ingredient concept found
NA,NA,human heterologous liver cells,,,,,,no ingredient concept found
NA,NA,human normal immunoglobulins - intravenous,,,,,,no ingredient concept found
NA,NA,human normal immunoglobulins - subcutaneous,,,,,,no ingredient concept found
NA,NA,human parathyroid hormone-related protein analogue,,,,,,no ingredient concept found
NA,NA,hydroxypropyl betadex,,,,,,no ingredient concept found
NA,NA,interferon alfa (pegylated and non-pegylated),,,,,,no ingredient concept found
NA,NA,invimestrocel,,,,,,no ingredient concept found
NA,NA,mercaptamine hcl viscous eyedrops,S01XA21,sensory organs,ophthalmologicals,other ophthalmologicals,other ophthalmologicals,no ingredient concept found
NA,NA,mesenchymal stem cells,,,,,,no ingredient concept found
NA,NA,"moroctocog alfa 
(factor viii - recombinant)",,,,,,no ingredient concept found
NA,NA,"nonacog alfa
(factor ix - recombinant)",,,,,,no ingredient concept found
NA,NA,"nonacog gamma
(factor ix - recombinant)",,,,,,no ingredient concept found
NA,NA,"octocog alfa 
(factor viii - recombinant)",,,,,,no ingredient concept found
NA,NA,octreolin,,,,,,no ingredient concept found
NA,NA,osteochondral allograft,,,,,,no ingredient concept found
NA,NA,palopegteriparatide,H05AA05,"systemic hormonal preparations, excl. sex hormones and insulins",calcium homeostatsis,parathyroid hormones and analogues,parathyroid hormones and analogues,no ingredient concept found
NA,NA,para-aminosalicylic acid,,,,,,no ingredient concept found
NA,NA,parenteral nutrition (home use),B05BA,blood and blood forming organs,blood substitutes and perfusion solutions,I.V. solutions ,solutions for parenteral nutrition,no ingredient concept found
NA,NA,parenteral nutrition (inpatient use),B05BA,blood and blood forming organs,blood substitutes and perfusion solutions,I.V. solutions ,solutions for parenteral nutrition,no ingredient concept found
NA,NA,pasireotide diaspartate,,,,,,no ingredient concept found
NA,NA,peginterferon alfa,,,,,,no ingredient concept found
NA,NA,peptide receptor radionucleotide therapy,,,,,,no ingredient concept found
NA,NA,platelet lysate therapy,,,,,,no ingredient concept found
NA,NA,protein kinase inhibitors,,,,,,no ingredient concept found
NA,NA,radium-223 dichloride,,,,,,no ingredient concept found
NA,NA,rivipansel sodium,,,,,,no ingredient concept found
NA,NA,rp-l102,,,,,,no ingredient concept found
NA,NA,rp-l201,,,,,,no ingredient concept found
NA,NA,sacituzumab govitecan,L01FX17,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,no ingredient concept found
NA,NA,"simoctocog alfa 
(factor viii - recombinant)",,,,,,no ingredient concept found
NA,NA,sitoiganap,,,,,,no ingredient concept found
NA,NA,sodium benzoate,A16AX11,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,no ingredient concept found
NA,NA,sodium oxybate,N01AX11; N07XX04,nervous system,anesthetics; other nervous system drugs,"anesthetics, general; other nervous system drugs",other general anesthetics; other nervous system drugs,no ingredient concept found
NA,NA,sodium phenylbutyrate,A16AX03,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,no ingredient concept found
NA,NA,sodium thiosulfate,,,,,,no ingredient concept found
NA,NA,sofosbuvir + peginterferon + ribavirin,,,,,,no ingredient concept found
NA,NA,strimvelis autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence,,,,,,no ingredient concept found
NA,NA,susoctocog alfa  (factor viii - porcine recombinant),B02BD14,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,no ingredient concept found
NA,NA,talimogene laherparepvec,L01XL02,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,no ingredient concept found
NA,NA,"thrombomodulin, recombinant human",,,,,,no ingredient concept found
NA,NA,tofersen sodium,,,,,,no ingredient concept found
NA,NA,trastuzumab emtansine,L01FD03,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,no ingredient concept found
NA,NA,treprostinil sodium,,,,,,no ingredient concept found
NA,NA,"turoctocog alfa 
(factor viii - recombinant)",,,,,,no ingredient concept found
746328,nadofaragene firadenovec,nadofarangene firadenovec,,,,,,
36857438,NARSOPLIMAB,narsoplimab,,,,,,
735843,natalizumab,natalizumab,L04AG03,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
36863201,NAVITOCLAX,navitoclax,L01XX78,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
35606215,necitumumab,necitumumab,L01FE03,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,EGFR (Epidermal Growth Factor Receptor) inhibitors,
42609137,nedosiran,nedosiran,A16AX25,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
19002912,nelarabine,nelarabine,L01BB07,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,purine analogues,
1715472,nelfinavir,nelfinavir,J05AE04,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
793846,neratinib,neratinib,L01EH02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,
1769389,nevirapine,nevirapine,J05AG01 ,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,non-nucleoside reverse transcriptase inhibitors,
1318137,nicardipine,nicardipine - intracranial implant,C08CA04 ,cardiovascular system,calcium channel blockers,selective calcium channel blockers with mainly vascular effects,dihydropyridine derivatives,
1394023,nilotinib,nilotinib,L01EA03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,BCR-ABL tyrosine kinase inhibitors,
45775396,nintedanib,nintedanib,L01EX09,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1593861,niraparib,niraparib,L01XK02,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,Poly (ADP-ribose) polymerase (PARP) inhibitors,
746155,nirsevimab,nirsevimab,J06BD08,antiinfectives for systemic use,immune sera and immunoglobulins,immunoglobulins,antiviral monoclonal antibodies,
1715315,nitazoxanide,nitazoxanide,P01AX11 ,"antiparasitic products, insecticides and repellents",antiprotozoals,agents against amoebiasis and other protozoal diseases,other agents against amoebiasis and other protozoal diseases,
1586640,nitisinone,nitisinone,A16AX04,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
19020068,nitric oxide,nitric oxide,R07AX01,respiratory system,other respiratory system products,other respiratory system products,other respiratory system products,
45892628,nivolumab,nivolumab,L01FF01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
2987225,Nonacog Beta Pegol,nonacog beta pegol (factor ix - recombinant),,,,,,
1593031,nusinersen,nusinersen,M09AX07,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
36853576,OBECABTAGENE AUTOLEUCEL,obecabtagene autoleucel,L01XL12,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
36250189,obeticholic acid,obeticholic acid,A05AA04,alimentary tract and metabolism,bile and liver therapy,bile therapy,bile acids and derivatives,
35603994,obiltoxaximab,obiltoxaximab,J06BC04,antiinfectives for systemic use,immune sera and immunoglobulins,immunoglobulins,antibacterial monoclonal antibodies,
44507676,obinutuzumab,obinutuzumab,L01FA03,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD20 (Clusters of Differentiation 20) inhibitors,
1593457,ocrelizumab,ocrelizumab,L04AG08,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
1522957,octreotide,octreotide,H01CB02,"systemic hormonal preparations, excl. sex hormones and insulins",pituitary and hypothalamic hormones and analogues,hypothalamic hormones,somatostatin and analogues,
701379,odevixibat,odevixibat,A05AX05,alimentary tract and metabolism,bile and liver therapy,bile therapy,other drugs for bile therapy ,
40167582,ofatumumab,ofatumumab,L01FA02; L04AG12,antineoplastic and immunomodulating agents,antineoplastic agents; immunosuppressants,monoclonal antibodies and antibody drug conjugates; immunosuppressants,CD20 (Clusters of Differentiation 20) inhibitors; monoclonal antibodies,
45892579,olaparib,olaparib,L01XK01,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,Poly (ADP-ribose) polymerase (PARP) inhibitors,
36853751,OLENASUFLIGENE RELDUPARVOVEC,olenasufligene relduparvovec,,,,,,
1525563,olipudase alfa,olipudase alfa,A16AB25,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1110942,omalizumab,omalizumab,R03DX05,respiratory system,drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,
45892552; 45892554; 1748921; 45892558; 1762711,ombitasvir; paritaprevir; ritonavir; dasabuvir; ribavirin,ombitasvir + paritaprevir+ ritonavir + dasabuvir + ribavirin,,,,,,multiple ingredients
1396458,onasemnogene abeparvovec,onasemnogene abeparvovec,M09AX09,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
37499303,osilodrostat,osilodrostat,H02CA02,"systemic hormonal preparations, excl. sex hormones and insulins",corticosteroids for systemic use,antiadrenal preparations,anticorticosteroids,
35605522,osimertinib,osimertinib,L01EB04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors,
37499437,ozanimod,ozanimod,L04AE02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,sphingosine-1-phosphate (S1P) receptor modulators,
902729; 42629079,Paclitaxel protein-bound; atezolizumab,nab-paclitaxel - albumin bound paclitaxel (with atezolizumab),,,,,,multiple ingredients
902729; 1314924,Paclitaxel protein-bound; gemcitabine,nab-paclitaxel - albumin bound paclitaxel (with gemcitabine),,,,,,multiple ingredients
779180,pacritinib,pacritinib,L01EJ03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Janus-associated kinase (JAK) inhibitors,
45892075,palbociclib,palbociclib,L01EF01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Cyclin-dependent kinase (CDK) inhibitors,
537647,palivizumab,palivizumab,J06BD01,antiinfectives for systemic use,immune sera and immunoglobulins,immunoglobulins,antiviral monoclonal antibodies,
746488,palovarotene,palovarotene,M09AX11,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
19100985,panitumumab,panitumumab,L01FE02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,EGFR (Epidermal Growth Factor Receptor) inhibitors,
46221435,panobinostat,panobinostat,L01XH03,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,histone deacetylase (HDAC) inhibitors,
43532113,parathyroid hormone,parathyroid hormone,H05AA03,"systemic hormonal preparations, excl. sex hormones and insulins",calcium homeostatsis,parathyroid hormones and analogues,parathyroid hormones and analogues,
1517740,paricalcitol,paricalcitol,H05BX02,"systemic hormonal preparations, excl. sex hormones and insulins",calcium homeostatsis,anti-parathyroid agents,other anti-parathyroid agents,
45892554,paritaprevir,paritaprevir,,,,,,
43012417,pasireotide,pasireotide,H01CB05,"systemic hormonal preparations, excl. sex hormones and insulins",pituitary and hypothalamic hormones and analogues,hypothalamic hormones,somatostatin and analogues,
35200163,patisiran,patisiran,N07XX12,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
40167554,pazopanib,pazopanib,L01EX03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1326481,pegaspargase,pegaspargase,L01XX24,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
36860339,PEGBELFERMIN,pegbelfermin,,,,,,
1537122,pegcetacoplan,pegcetacoplan,L04AJ03; S01XA31,antineoplastic and immunomodulating agents; sensory organs,immunosuppressants; ophthalmologicals,immunosuppressants; other ophthalmologicals,complement inhibitors; other ophthalmologicals,
45775146,peginterferon beta-1a,peginterferon beta-1a,L03AB13,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,interferons,
1201228,pegunigalsidase alfa,pegunigalsidase alfa,A16AB20,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1510552,pegvaliase,pegvaliase,A16AB19,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1503432,pegvisomant,pegvisomant,H01AX01,"systemic hormonal preparations, excl. sex hormones and insulins",pituitary and hypothalamic hormones and analogues,anterior pituitary lobe hormones and analogues,other anterior pituitary lobe hormones and analogues,
45775965,pembrolizumab,pembrolizumab,L01FF02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors,
1304919,pemetrexed,pemetrexed,L01BA04,antineoplastic and immunomodulating agents,antineoplastic agents,antimetabolites,folic acid analogues,
37499576,pemigatinib,pemigatinib,L01EN02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors,
42801287,pertuzumab,pertuzumab,L01FD02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,
793844,pibrentasvir,pibrentasvir,,,,,,
45775206,pirfenidone,pirfenidone,L04AX05,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
36879010,Pixantrone,pixantrone,L01DB11,antineoplastic and immunomodulating agents,antineoplastic agents,cytotoxic antibiotics and related substances,anthracyclines and related substances,
19017581,plerixafor,plerixafor,L03AX16,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,other immunostimulants,
1396729,polatuzumab vedotin,polatuzumab vedotin,L01FX14,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
43014237,pomalidomide,pomalidomide,L04AX06,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
43013182,ponatinib,ponatinib,L01EA05,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,BCR-ABL tyrosine kinase inhibitors,
740121,ponesimod,ponesimod,L04AE04,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,sphingosine-1-phosphate (S1P) receptor modulators,
1704139,posaconazole,posaconazole,J02AC04,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,triazole and tetrazole derivatives,
37002765,pralsetinib,pralsetinib,L01EX23,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,other protein kinase inhibitors,
37496482,pretomanid,pretomanid,J04AK08,antiinfectives for systemic use,antimycobacterials,drugs for treatment of tuberculosis,other drugs for treatment of tuberculosis,
42801108,protein C,protein c human (acute use),B01AD12,blood and blood forming organs,antithrombotic agents,antithrombotic agents,enzymes,specified duration of use
42801108,protein C,protein c human (long-term use),B01AD12,blood and blood forming organs,antithrombotic agents,antithrombotic agents,enzymes,specified duration of use
1254255,Prothrombin complex concentrate,prothrombin complex concentrate (pcc),,,,,,
746225,quizartinib,quizartinib,L01EX11,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,other protein kinase inhibitors,
1712889,raltegravir,raltegravir,J05AJ01,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,integrase inhibitors,
44818489,ramucirumab,ramucirumab,L01FG02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors,
19080982,ranibizumab,ranibizumab,S01LA04,sensory organs,ophthalmologicals,ocular vascular disorder agents,antineovascularisation agents,
1304565,rasburicase,rasburicase,V03AF07,various,all other therapeutic products,all other therapeutic products,detoxifying agents for antineoplastic treatment,
1356009,ravulizumab,ravulizumab,L04AJ02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
35884341,Recombinant Human Granulocyte Colony-Stimulating Factor,granulocyte-macrophage colony-stimulating factor,,,,,,
42903460,regorafenib,regorafenib,L01EX05,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
779239,relatlimab,relatlimab,,,,,,
36861995,REPARIXIN,reparixin,,,,,,
35603983,reslizumab,reslizumab,R03DX08,respiratory system,drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,
1201411,rezafungin,rezafungin,,,,,,
1592911,ribociclib,ribociclib,L01EF02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Cyclin-dependent kinase (CDK) inhibitors,
40238930,rilpivirine,rilpivirine,J05AG05,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,non-nucleoside reverse transcriptase inhibitors,
44506752,riociguat,riociguat,C02KX05,cardiovascular system,antihypertensives,other antihypertensives,antihypertensives for pulmonary arterial hypertension,
1145752,ripretinib,ripretinib,L01EX19,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1511348,risankizumab,risankizumab,L04AC18,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
37002532,risdiplam,risdiplam,M09AX10,musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,other drugs for disorders of the musculo-skeletal system,
1748921,ritonavir,ritonavir,J05AE03,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
1314273,rituximab,rituximab,L01FA01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD20 (Clusters of Differentiation 20) inhibitors,specific route
1314273,rituximab,rituximab iv,L01FA01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD20 (Clusters of Differentiation 20) inhibitors,specific route
1314273,rituximab,rituximab subcutaneous formulation,L01FA02,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,CD20 (Clusters of Differentiation 20) inhibitors,
702407,ropeginterferon alfa-2b,ropeginterferon alfa-2b ,,,,,,
1718850,rucaparib,rucaparib,L01XK03,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,Poly (ADP-ribose) polymerase (PARP) inhibitors,
2997891,Rurioctocog Alfa Pegol,rurioctocog alfa pegol (factor viii - recombinant),,,,,,
40244464,ruxolitinib,ruxolitinib,D11AH09; L01EJ01,dermatologicals;  antineoplastic and immunomodulating agents,other dermatological preparations; antineoplastic agents,other dermatological preparations; protein kinase inhibitors,"agents for dermatitis, excluding corticosteroids; Janus-associated kinase (JAK) inhibitors",
19021959,sapropterin,sapropterin,A16AX07,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
1746244,saquinavir,saquinavir,J05AE01,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
37002573,satralizumab,satralizumab,L04AC19,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
35604495,sebelipase alfa,sebelipase alfa,A16AB14,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
45892883,secukinumab,secukinumab,L04AC10,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
35604848,selexipag,selexipag,B01AC27,blood and blood forming organs,antithrombotic agents,antithrombotic agents,platelet aggregation inhibitors excl. heparin,
1361191,selinexor,selinexor,L01XX66,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
1145791,selpercatinib,selpercatinib,L01EX22,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
37499520,selumetinib,selumetinib,L01EE04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,mitogen-activated protein kinase (MEK) inhibitors,
37003477,setmelanotide,setmelanotide,A08AA12,alimentary tract and metabolism,"antiobesity preparations, excl. diet products","antiobesity preparations, excl. diet products",centrally acting antiobesity products,
36857413,SETRUSUMAB,setrusumab,,,,,,
1316262,sildenafil,sildenafil,G04BE03,genito urinary system and sex hormones,urologicals,urologicals,drugs used in erectile dysfunction,
44818461,siltuximab,siltuximab,L04AC11,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
1510913,siponimod,siponimod,L04AE03,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,Sphingosine-1-phosphate (S1P) receptor modulators,
19034726,sirolimus,sirolimus,L01EG04; L04AH01;  S01XA23,antineoplastic and immunomodulating agents; antineoplastic and immunomodulating agents; sensory organs,antineoplastic agents; immunosuppressants; ophthalmologicals,protein kinase inhibitors; immunosuppressants; other ophthalmologicals,mammalian target of rapamycin (mTOR) kinase inhibitors; mammalian target of rapamycin (mTOR) kinase inhibitors; other ophthalmologicals,
36879243,Sodium hydroxybutyrate,sodium hydroxybutyrate,,,,,,
44785094; 45775020; 1762711,sofosbuvir; ledipasvir; ribavirin,sofosbuvir + ledipasvir +/- ribavirin,J05AP51,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,multiple ingredients
44785096; 36249204,sofosbuvir; velpatasvir,sofosbuvir + velpatasvir,J05AP55,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,multiple ingredients
44785096; 36249205; 793741,sofosbuvir; velpatasvir; voxilaprevir,sofosbuvir + velpatasvir + voxilaprevir,J05AP56,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,antivirals for treatment of HCV infections,multiple ingredients
1363387,sorafenib,sorafenib,L01EX02,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
42609512,sotatercept,sotatercept,C02KX06,cardiovascular system,antihypertensives,other antihypertensives,antihypertensives for pulmonary arterial hypertension,
1536963,sotorasib,sotorasib,L01XX73,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
1781406,stavudine,stavudine,J05AF04 ,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
44785066,sucroferric oxyhydroxide,sucroferric oxyhydroxide,V03AE05,various,all other therapeutic products,all other therapeutic products,drugs for treatment of hyperkalemia and hyperphosphatemia,
1336539,sunitinib,sunitinib,L01EX01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
1758949,sutimlimab,sutimlimab,L04AJ04,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
36857534,TABELECLEUCEL,tabelecleucel,L01XL09,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
950637,tacrolimus,tacrolimus,D11AH01; L04AD02,dermatologicals; antineoplastic and immunomodulating agents,other dermatological preparations; immunosuppressants,other dermatological preparations; immunosuppressants,"agents for dermatitis, excluding corticosteroids; calcineurin inhibitors",
1336926,tadalafil,tadalafil,G04BE08,genito urinary system and sex hormones,urologicals,urologicals,drugs used in erectile dysfunction,
45774701,tafamidis,tafamidis,N07XX08,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
37002368,tafasitamab,tafasitamab,L01FX12,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
1356361,tagraxofusp,tagraxofusp,L01XX67,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
35201068,talazoparib,talazoparib,L01XK04,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,Poly (ADP-ribose) polymerase (PARP) inhibitors,
19071159,tasonermin,tasonermin,L03AX11,antineoplastic and immunomodulating agents,immunostimulants,immunostimulants,other immunostimulants,
1758886,tebentafusp,tebentafusp,L01XX75,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
741578,teclistamab,teclistamab,L01FX24 ,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,other monoclonal antibodies and antibody drug conjugates,
43013171,teduglutide,teduglutide,A16AX08,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
1758392,telbivudine,telbivudine,J05AF11,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
1592537,telotristat,telotristat,A16AX15,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
1341149,temozolomide,temozolomide,L01AX03,antineoplastic and immunomodulating agents,antineoplastic agents,alkylating agents,other alkylating agents,
19092845,temsirolimus,temsirolimus,L01EG01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,mammalian target of rapamycin (mTOR) kinase inhibitors,
19011093,tenofovir,tenofovir,,,,,,
35605546,tenofovir alafenamide,tenofovir alafenamide,J05AF13,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
1710281,tenofovir disoproxil,tenofovir disoproxil,J05AF07,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
739739,tepotinib,tepotinib,L01EX21,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,other protein kinase inhibitors,
36859974,TEPRASIRAN,teprasiran,,,,,,
37498633,teprotumumab,teprotumumab,L04AG13,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
42900584,teriflunomide,teriflunomide,L04AK02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,dihydroorotate dehydrogenase (DHODH) inhibitors,
963950; 42709323,tezacaftor; ivacaftor,tezacaftor + ivacaftor,R07AX31,respiratory system,other respiratory system products,other respiratory system products,other respiratory system products,multiple ingredients
702498,tezepelumab,tezepelumab,R03DX11,respiratory system,drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,other systemic drugs for obstructive airway diseases,
19137042,thalidomide,thalidomide,L04AX02,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,other immunosuppressants,
36860693,TIDEGLUSIB,tideglusib,,,,,,
1736999,tipranavir,tipranavir,J05AE09,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,protease inhibitors,
792737,tisagenlecleucel,tisagenlecleucel,L01XL04,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,antineoplastic cell and gene therapy,
36026750,tivozanib,tivozanib,L01EK03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors,
902722,tobramycin,tobramycin,J01GB01; S01AA12,antiinfectives for systemic use; sensory organs,antibacterials for systemic use; ophthalmologicals,aminoglycoside antibacterials; antiinfectives,other aminoglycosides; antibiotics,
40171288,tocilizumab,tocilizumab,L04AC07,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
42904205,tofacitinib,tofacitinib,L04AF01,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,Janus-associated kinase (JAK) inhibitors,
19036797,tolvaptan,tolvaptan,C03XA01,cardiovascular system,diuretics,other diuretics,vasopressin antagonists,
35603017,trabectedin,trabectedin,L01CX01,antineoplastic and immunomodulating agents,antineoplastic agents,plant alkaloids and other natural products,other plant alkaloids and natural products,
1758687,tralokinumab,tralokinumab,D11AH07,dermatologicals ,other dermatological preparations,other dermatological preparations,"agents for dermatitis, excluding corticosteroids",
43532497,trametinib,trametinib,L01EE01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Mitogen-activated protein kinase (MEK) inhibitors,
1387104,trastuzumab,trastuzumab,L01FD01,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,
36118944,Trastuzumab deruxtecan,trastuzumab deruxtecan,L01FD04,antineoplastic and immunomodulating agents,antineoplastic agents,monoclonal antibodies and antibody drug conjugates,HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors,
19042545,treosulfan,treosulfan,L01AB02,antineoplastic and immunomodulating agents,antineoplastic agents,alkylating agents,alkyl sulfonates,
19004969,trientine,trientine,A16AX12,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
905078; 35602757,trifluridine; tipiracil,trifluridine-tipiracil,,,,,,multiple ingredients
42903571,triheptanoin,triheptanoin,A16AX17,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
1145571,tucatinib,tucatinib,L01EH03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors,
36855419,TUROCTOCOG ALFA PEGOL,turoctocog alfa pegol (factor viii - recombinant),,,,,,
1301397,ublituximab,ublituximab,L04AG14,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
1361580,upadacitinib,upadacitinib,L04AF03,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,Janus-associated kinase (JAK) inhibitors,
46287389,uridine triacetate,uridine triacetate,A16AX13,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,various alimentary tract and metabolism products,
40161532,ustekinumab,ustekinumab,L04AC05,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,interleukin inhibitors,
42609572,vadadustat,vadadustat,B03XA08,blood and blood forming organs,antianemic preparations,other antianemic preparations,other antianemic preparations,
745985,valoctocogene roxaparvovec,valoctocogene roxaparvovec,B02BD15,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
747167,vamorolone,vamorolone,H02AB18,"systemic hormonal preparations, excl. sex hormones and insulins",corticosteroids for systemic use,"corticosteroids for systemic use, plain",glucocorticoids,
40238052,vandetanib,vandetanib,L01EX04,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors ,other protein kinase inhibitors,
36853229,VATIQUINONE,vatiquinone,,,,,,
45774639,vedolizumab,vedolizumab,L04AG05,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,monoclonal antibodies,
40174604,velaglucerase alfa,velaglucerase alfa,A16AB10,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
1301780,velmanase alfa,velmanase alfa,A16AB15,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
40241937,vemurafenib,vemurafenib,L01EC01,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,B-Raf serine-threonine kinase (BRAF) inhibitors,
35604205,venetoclax,venetoclax,L01XX52,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,other antineoplastic agents,
793066,vestronidase alfa,vestronidase alfa,A16AB18,alimentary tract and metabolism,other alimentary tract and metabolism products,other alimentary tract and metabolism products,enzymes,
42709321,vismodegib,vismodegib,L01XJ01,antineoplastic and immunomodulating agents,antineoplastic agents,other antineoplastic agents,hedgehog pathway inhibitors,
739590,voclosporin,voclosporin,L04AD03,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,calcineurin inhibitors,
1201198,volanesorsen,volanesorsen,C10AX18,cardiovascular system,lipid modifying agents,"lipid modifying agents, plain",other lipid modifying agents,
44785885,von Willebrand factor,von willebrand factor (von willebrand factor - plasma derived),B02BD10,blood and blood forming organs,antihemorrhagics,vitamin K and other hemostatics,blood coagulation factors,
1718111,vonicog alfa,vonicog alfa (von willebrand factor - recombinant),,,,,,
793440,voretigene neparvovec,voretigene neparvovec,S01XA27,sensory organs,ophthalmologicals,other ophthalmologicals,other ophthalmologicals,
1714277,voriconazole,voriconazole,J02AC03,antiinfectives for systemic use,antimycotics for systemic use,antimycotics for systemic use,triazole and tetrazole derivatives,
702318,vosoritide,vosoritide,M05BX07,musculo-skeletal system,drugs for treatment of bone diseases,drugs affecting bone structure and mineralization,other drugs affecting bone structure and mineralization,
779985,vutrisiran,vutrisiran,N07XX18,nervous system,other nervous system drugs,other nervous system drugs,other nervous system drugs,
37497691,zanubrutinib,zanubrutinib,L01EL03,antineoplastic and immunomodulating agents,antineoplastic agents,protein kinase inhibitors,Bruton's tyrosine kinase (BTK) inhibitors,
1710612,zidovudine,zidovudine,J05AF01,antiinfectives for systemic use,antivirals for systemic use,direct acting antivirals,nucleoside and nucleotide reverse transcriptase inhibitors,
42608934,zilucoplan,zilucoplan,L04AJ06,antineoplastic and immunomodulating agents,immunosuppressants,immunosuppressants,complement inhibitors,
NA,NA,"lonoctocog alfa
(factor viii - recombinant)",,,,,,no ingredient concept found
NA,NA,lutetium (177lu) oxodotreotide,V10XX04,various,therapeutic radiopharmaceuticals ,other therapeutic radiopharmaceuticals,various therapeutic radiopharmaceuticals,no ingredient concept found
